CapEx at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s capex?
- Tarsus Pharmaceuticals, Inc. (TARS) reported capex of $5.82M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s capex changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s capex increased by 886.1% year-over-year, from $590K to $5.82M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s capex?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s capex has grown at a 102.5% compound annual growth rate (CAGR), from $586K to $9.86M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.